Comments

Cingulate Stock Price, Quotes and Forecasts

Q: What sector and industry does Cingulate (CING) operate in?

Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

CINGNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$4.45

0.000.00%

At close: -

$4.58

0.132.92%

After Hours: Jun 18, 5:28 PM EDT

Cingulate (CING) Forecast

News Earnings Cingulate (CING) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Cingulate Stock Price, Quotes and Forecasts | NASDAQ:CING | Benzinga

Explore Cingulate stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CING.

Open	$4.40
Close	$4.45
Volume / Avg.	147.69K / 146.50K
Day Range	$4.35 - $4.69
52 Wk Range	1.80 - 20.83
Market Cap	$19.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	58
Short Interest	7.6%
Days to Cover	1

Recent News

Meta Platforms To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?

A look at the top 20 most-searched tickers on Benzinga Pro for the month of August.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.40
Close	$4.45
Volume / Avg.	147.69K / 146.50K
Day Range	$4.35 - $4.69
52 Wk Range	1.80 - 20.83
Market Cap	$19.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	58
Short Interest	7.6%
Days to Cover	1

About Cingulate Inc

Sector

Health Care

Industry

Pharmaceuticals

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision time...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cingulate (CING) stock?

You can purchase shares of Cingulate (NASDAQ:CING) through any online brokerage.

View our list of the best stock brokerages

Who are Cingulate (CING) competitors?

Other companies in Cingulate’s space includes: Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Rani Therapeutics Hldgs (NASDAQ:RANI).

What is the forecast, or price target, for Cingulate (CING) stock?

Cingulate has a consensus price target of $26.00.

What is the current price for Cingulate (CING)?

The stock price for Cingulate (NASDAQ: CING) is $4.58 last updated June 18, 2025 at 5:28 PM EDT.

Does Cingulate (CING) pay a dividend?

There are no upcoming dividends for Cingulate.

When is Cingulate (NASDAQ:CING) reporting earnings?

Cingulate’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is Cingulate (CING) going to split?

There is no upcoming split for Cingulate.

What sector and industry does Cingulate (CING) operate in?

Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.